Medication and psychotherapy treat depression

July 01, 2003

Treatment with medication or psychotherapy reduced depressive symptoms in women from minority populations, according to research funded by the National Institute of Mental Health (NIMH). Most of the participants in the controlled trial were low-income African-American and Latino women who are at high risk for depression and use county health and welfare services. Research findings appear in the July 2 issue of the Journal of the American Medical Association.

Participants were randomly assigned an antidepressant, psychotherapy, or referral to a community mental health service provider. "Structured care reduces major depression in these diverse and impoverished patients," said lead author Jeanne Miranda, Ph.D., University of California at Los Angeles Neuropsychiatric Institute. "This study broadens the knowledge base by evaluating depression treatments among young, predominantly minority women. It is the first study to let providers know that treating depression in this population can significantly improve the ability of these women to feel and function."

Results show that low-income women in minority populations benefit from depression treatment when it is paired with intensive outreach and encouragement to support the interventions. Not only did women achieve lower levels of depressive symptoms, but they also gained higher levels of functioning in daily life.

Outreach support¾ including transportation, child care, and spending considerable time to gain the trust of these participants¾was an essential part of the study. Miranda and colleagues screened thousands of women for ethnicity, major depression, and exclusionary factors while they attended Women, Infants, and Children food subsidy programs and family planning clinics in four suburban counties near Washington, D.C.

Three cultural groups were recruited. Of the 276 women who met criteria, consented to treatment, and were randomized in the trial, 117 were black women, 134 were Latina women, and 16 were white women. The median age was 29.3, 60 percent lived at or below the federal guidelines for poverty, and 37.1 percent had not graduated from high school. The women had experienced extremely high rates of trauma exposure, including rape, child abuse, and domestic violence. High rates of post-traumatic stress disorder were also found.

Each month for six months, participants completed a version of a standard psychiatric measuring tool to compare depression symptom and functioning scores over time.

Women assigned to medication were treated with paroxetine for 6 months. If a patient did not tolerate the antidepressant or show a significant response, buproprion, an antidepressant with a different medical profile, was prescribed. Women assigned to psychotherapy were treated by experienced psychotherapists in 8 weekly cognitive behavioral therapy (CBT) sessions. The treatments were most often provided in or near the county clinic where the women were identified. CBT taught participants techniques to manage mood, disprove thinking that may keep them depressed, engage in pleasant activities, reverse self-defeating beliefs, and get social support from others.

Medications and psychotherapy were both significantly more effective in decreasing depressive symptoms than the community referral sample, which received little treatment. With community referral, researchers made appointments for care, but very few women attended the sessions.

Medications were more effective than no treatment at 6 months for reducing patients' depressive symptoms, improving home and work life, and increasing their ability to get along with others and engage in social activities. Psychotherapy was more effective than no treatment at 6 months for decreasing depressive symptoms and relating to others, but it did not improve home and work life.

The 88 women in the medication group were twice as likely as those referred to community care to achieve a significant reduction on depression rating scale scores.

Researchers believe that without outreach involving education, encouragement to comply with treatment, transportation, and childcare, few poor women are likely to receive appropriate depression treatment. Results suggest that treating depression in this population improves the functioning of these young women if they have tools to overcome barriers to care and receive treatment services.
NIMH is part of the National Institutes of Health (NIH), the Federal Government's primary agency for biomedical and behavioral research. NIH is a component of the U.S. Department of Health and Human Services.

NIH/National Institute of Mental Health

Related Depression Articles from Brightsurf:

Children with social anxiety, maternal history of depression more likely to develop depression
Although researchers have known for decades that depression runs in families, new research from Binghamton University, State University of New York, suggests that children suffering from social anxiety may be at particular risk for depression in the future.

Depression and use of marijuana among US adults
This study examined the association of depression with cannabis use among US adults and the trends for this association from 2005 to 2016.

Maternal depression increases odds of depression in offspring, study shows
Depression in mothers during and after pregnancy increased the odds of depression in offspring during adolescence and adulthood by 70%.

Targeting depression: Researchers ID symptom-specific targets for treatment of depression
For the first time, physician-scientists at Beth Israel Deaconess Medical Center have identified two clusters of depressive symptoms that responded to two distinct neuroanatomical treatment targets in patients who underwent transcranial magnetic brain stimulation (TMS) for treatment of depression.

A biological mechanism for depression
Researchers report that in depressed individuals there are increased amounts of an unmodified structural protein, called tubulin, in lipid rafts compared with non-depressed individuals.

Depression in adults who are overweight or obese
In an analysis of primary care records of 519,513 UK adults who were overweight or obese between 2000-2016 and followed up until 2019, the incidence of new cases of depression was 92 per 10,000 people per year.

Why stress doesn't always cause depression
Rats susceptible to anhedonia, a core symptom of depression, possess more serotonin neurons after being exposed to chronic stress, but the effect can be reversed through amygdala activation, according to new research in JNeurosci.

Which comes first: Smartphone dependency or depression?
New research suggests a person's reliance on his or her smartphone predicts greater loneliness and depressive symptoms, as opposed to the other way around.

Depression breakthrough
Major depressive disorder -- referred to colloquially as the 'black dog' -- has been identified as a genetic cause for 20 distinct diseases, providing vital information to help detect and manage high rates of physical illnesses in people diagnosed with depression.

CPAP provides relief from depression
Researchers have found that continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA) can improve depression symptoms in patients suffering from cardiovascular diseases.

Read More: Depression News and Depression Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to